Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renoprotection in Early Diabetic Nephropathy in Pima Indians
NCT00340678Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Aug 1995
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of losartan in diabetic nephropathy (DN) (4 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Number of Participants With Decline in GFR at 6 years. Started Aug 1995; status: completed.
02
Drugs
losartan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00340678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00340678.